Ignite Creation Date:
2025-12-24 @ 4:19 PM
Ignite Modification Date:
2026-03-03 @ 12:44 AM
Study NCT ID:
NCT02885766
Status:
UNKNOWN
Last Update Posted:
2020-02-17
First Post:
2016-08-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy of PF-114 for Oral Administration in Adults With Ph+ Chronic Myeloid Leukemia, Which is Resistant to the 2-nd Generation Bcr-Abl Inhibitors or Has T315I Mutation in the BCR-ABL Gene
Sponsor:
Fusion Pharma LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-07
Start Date Type:
ACTUAL
Primary Completion Date:
2018-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-05
Completion Date Type:
ESTIMATED
First Submit Date:
2016-08-03
First Submit QC Date:
None
Study First Post Date:
2016-08-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-13
Last Update Post Date:
2020-02-17
Last Update Post Date Type:
ACTUAL